Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Laparoscopic Revision of Bariatric Surgeries in Two Patients with Severe Resistant Hypocalcemia After Endocrine Cervical Surgery.

Zaarour M, Zaharia R, Bretault M, Jublanc C, De Marcellus C, Bouillot JL, Lefebvre H, Oppert JM, Aron-Wisnewsky J, Raffin-Sanson ML.

Obes Surg. 2019 Aug 28. doi: 10.1007/s11695-019-04132-8. [Epub ahead of print]

PMID:
31463800
2.

Akkermansia muciniphila abundance is lower in severe obesity, but its increased level after bariatric surgery is not associated with metabolic health improvement.

Dao MC, Belda E, Prifti E, Everard A, Kayser BD, Bouillot JL, Chevallier JM, Pons N, Le Chatelier E, Ehrlich SD, Doré J, Aron-Wisnewsky J, Zucker JD, Cani PD, Clément K.

Am J Physiol Endocrinol Metab. 2019 Sep 1;317(3):E446-E459. doi: 10.1152/ajpendo.00140.2019. Epub 2019 Jul 2.

PMID:
31265324
3.

Fecal Microbiota Transplantation: a Future Therapeutic Option for Obesity/Diabetes?

Aron-Wisnewsky J, Clément K, Nieuwdorp M.

Curr Diab Rep. 2019 Jun 27;19(8):51. doi: 10.1007/s11892-019-1180-z. Review.

PMID:
31250122
4.

Changes in Body Composition, Comorbidities, and Nutritional Status Associated with Lower Weight Loss After Bariatric Surgery in Older Subjects.

Faucher P, Aron-Wisnewsky J, Ciangura C, Genser L, Torcivia A, Bouillot JL, Poitou C, Oppert JM.

Obes Surg. 2019 Jun 25. doi: 10.1007/s11695-019-04037-6. [Epub ahead of print]

PMID:
31240537
5.

Gut Microbiota Dysbiosis in Human Obesity: Impact of Bariatric Surgery.

Debédat J, Clément K, Aron-Wisnewsky J.

Curr Obes Rep. 2019 Sep;8(3):229-242. doi: 10.1007/s13679-019-00351-3. Review.

PMID:
31197613
6.

Impact of bariatric surgery on type 2 diabetes: contribution of inflammation and gut microbiome?

Debédat J, Amouyal C, Aron-Wisnewsky J, Clément K.

Semin Immunopathol. 2019 Jul;41(4):461-475. doi: 10.1007/s00281-019-00738-3. Epub 2019 Apr 25. Review.

PMID:
31025085
7.

A Data Integration Multi-Omics Approach to Study Calorie Restriction-Induced Changes in Insulin Sensitivity.

Dao MC, Sokolovska N, Brazeilles R, Affeldt S, Pelloux V, Prifti E, Chilloux J, Verger EO, Kayser BD, Aron-Wisnewsky J, Ichou F, Pujos-Guillot E, Hoyles L, Juste C, Doré J, Dumas ME, Rizkalla SW, Holmes BA, Zucker JD, Clément K; MICRO-Obes Consortium.

Front Physiol. 2019 Feb 5;9:1958. doi: 10.3389/fphys.2018.01958. eCollection 2018.

8.

Comparative Evaluation of Microbiota Engraftment Following Fecal Microbiota Transfer in Mice Models: Age, Kinetic and Microbial Status Matter.

Le Roy T, Debédat J, Marquet F, Da-Cunha C, Ichou F, Guerre-Millo M, Kapel N, Aron-Wisnewsky J, Clément K.

Front Microbiol. 2019 Jan 14;9:3289. doi: 10.3389/fmicb.2018.03289. eCollection 2018.

9.

Phosphatidylglycerols are induced by gut dysbiosis and inflammation, and favorably modulate adipose tissue remodeling in obesity.

Kayser BD, Lhomme M, Prifti E, Da Cunha C, Marquet F, Chain F, Naas I, Pelloux V, Dao MC, Kontush A, Rizkalla SW, Aron-Wisnewsky J, Bermúdez-Humarán LG, Oakley F, Langella P, Clément K, Dugail I.

FASEB J. 2019 Apr;33(4):4741-4754. doi: 10.1096/fj.201801897R. Epub 2019 Jan 4.

PMID:
30608881
10.

Prediction of Long-Term Diabetes Remission After RYGB, Sleeve Gastrectomy, and Adjustable Gastric Banding Using DiaRem and Advanced-DiaRem Scores.

Dicker D, Golan R, Aron-Wisnewsky J, Zucker JD, Sokolowska N, Comaneshter DS, Yahalom R, Vinker S, Clément K, Rudich A.

Obes Surg. 2019 Mar;29(3):796-804. doi: 10.1007/s11695-018-3583-3.

PMID:
30467708
11.

Long-term Relapse of Type 2 Diabetes After Roux-en-Y Gastric Bypass: Prediction and Clinical Relevance.

Debédat J, Sokolovska N, Coupaye M, Panunzi S, Chakaroun R, Genser L, de Turenne G, Bouillot JL, Poitou C, Oppert JM, Blüher M, Stumvoll M, Mingrone G, Ledoux S, Zucker JD, Clément K, Aron-Wisnewsky J.

Diabetes Care. 2018 Oct;41(10):2086-2095. doi: 10.2337/dc18-0567. Epub 2018 Aug 6.

PMID:
30082327
12.

Mucosal-associated invariant T (MAIT) cells are depleted and prone to apoptosis in cardiometabolic disorders.

Touch S, Assmann KE, Aron-Wisnewsky J, Marquet F, Rouault C, Fradet M, Mosbah H, Consortium M, Isnard R, Helft G, Lehuen A, Poitou C, Clément K, André S; MetaCardis Consortium.

FASEB J. 2018 Apr 27:fj201800052RR. doi: 10.1096/fj.201800052RR. [Epub ahead of print]

PMID:
29957059
13.

Major microbiota dysbiosis in severe obesity: fate after bariatric surgery.

Aron-Wisnewsky J, Prifti E, Belda E, Ichou F, Kayser BD, Dao MC, Verger EO, Hedjazi L, Bouillot JL, Chevallier JM, Pons N, Le Chatelier E, Levenez F, Ehrlich SD, Dore J, Zucker JD, Clément K.

Gut. 2019 Jan;68(1):70-82. doi: 10.1136/gutjnl-2018-316103. Epub 2018 Jun 13.

PMID:
29899081
14.

Sleeve Gastrectomy in Morbidly Obese HIV Patients: Focus on Anti-retroviral Treatment Absorption After Surgery.

Amouyal C, Buyse M, Lucas-Martini L, Hirt D, Genser L, Torcivia A, Bouillot JL, Oppert JM, Aron-Wisnewsky J.

Obes Surg. 2018 Sep;28(9):2886-2893. doi: 10.1007/s11695-018-3308-7.

PMID:
29781044
15.

Pharmacologic Venous Thromboprophylaxis After Bariatric Surgery: Burning Questions Regarding Doses, Duration, and Strategy.

Gaborit B, Aron-Wisnewsky J, Salem JE, Bege T, Frere C.

Ann Surg. 2018 Dec;268(6):e51-e52. doi: 10.1097/SLA.0000000000002536. No abstract available.

PMID:
28938272
16.

The advanced-DiaRem score improves prediction of diabetes remission 1 year post-Roux-en-Y gastric bypass.

Aron-Wisnewsky J, Sokolovska N, Liu Y, Comaneshter DS, Vinker S, Pecht T, Poitou C, Oppert JM, Bouillot JL, Genser L, Dicker D, Zucker JD, Rudich A, Clément K.

Diabetologia. 2017 Oct;60(10):1892-1902. doi: 10.1007/s00125-017-4371-7. Epub 2017 Jul 21.

PMID:
28733906
17.

Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease.

Viglino D, Jullian-Desayes I, Minoves M, Aron-Wisnewsky J, Leroy V, Zarski JP, Tamisier R, Joyeux-Faure M, Pépin JL.

Eur Respir J. 2017 Jun 8;49(6). pii: 1601923. doi: 10.1183/13993003.01923-2016. Print 2017 Jun.

18.

Immune cell-derived cytokines contribute to obesity-related inflammation, fibrogenesis and metabolic deregulation in human adipose tissue.

Caër C, Rouault C, Le Roy T, Poitou C, Aron-Wisnewsky J, Torcivia A, Bichet JC, Clément K, Guerre-Millo M, André S.

Sci Rep. 2017 Jun 7;7(1):3000. doi: 10.1038/s41598-017-02660-w.

19.

Decision-making in obesity without eating disorders: a systematic review and meta-analysis of Iowa gambling task performances.

Rotge JY, Poitou C, Fossati P, Aron-Wisnewsky J, Oppert JM.

Obes Rev. 2017 Aug;18(8):936-942. doi: 10.1111/obr.12549. Epub 2017 Apr 21. Review.

PMID:
28429468
20.

The FAT Score, a Fibrosis Score of Adipose Tissue: Predicting Weight-Loss Outcome After Gastric Bypass.

Bel Lassen P, Charlotte F, Liu Y, Bedossa P, Le Naour G, Tordjman J, Poitou C, Bouillot JL, Genser L, Zucker JD, Sokolovska N, Aron-Wisnewsky J, Clément K.

J Clin Endocrinol Metab. 2017 Jul 1;102(7):2443-2453. doi: 10.1210/jc.2017-00138.

PMID:
28419237
21.

Diabetes remission after bariatric surgery in obese patients with haemochromatosis.

Phan F, Vatier C, Vauloup-Soupault C, Poitou C, Bouillot JL, Oppert JM, Aron-Wisnewsky J.

Diabetes Metab. 2018 Mar;44(2):185-187. doi: 10.1016/j.diabet.2017.02.005. Epub 2017 Mar 14. No abstract available.

PMID:
28314670
22.

Serum lipidomics reveals early differential effects of gastric bypass compared with banding on phospholipids and sphingolipids independent of differences in weight loss.

Kayser BD, Lhomme M, Dao MC, Ichou F, Bouillot JL, Prifti E, Kontush A, Chevallier JM, Aron-Wisnewsky J, Dugail I, Clément K.

Int J Obes (Lond). 2017 Jun;41(6):917-925. doi: 10.1038/ijo.2017.63. Epub 2017 Mar 10.

PMID:
28280270
23.

A PDGFRα-Mediated Switch toward CD9high Adipocyte Progenitors Controls Obesity-Induced Adipose Tissue Fibrosis.

Marcelin G, Ferreira A, Liu Y, Atlan M, Aron-Wisnewsky J, Pelloux V, Botbol Y, Ambrosini M, Fradet M, Rouault C, Hénégar C, Hulot JS, Poitou C, Torcivia A, Nail-Barthelemy R, Bichet JC, Gautier EL, Clément K.

Cell Metab. 2017 Mar 7;25(3):673-685. doi: 10.1016/j.cmet.2017.01.010. Epub 2017 Feb 16.

24.

Dietary Assessment in the MetaCardis Study: Development and Relative Validity of an Online Food Frequency Questionnaire.

Verger EO, Armstrong P, Nielsen T, Chakaroun R, Aron-Wisnewsky J, Gøbel RJ, Schütz T, Delaere F, Gausseres N, Clément K, Holmes BA; MetaCardis Consortium.

J Acad Nutr Diet. 2017 Jun;117(6):878-888. doi: 10.1016/j.jand.2016.10.030. Epub 2016 Dec 23.

PMID:
28024800
25.

[A cooperation protocol for the follow-up of patients after bariatric surgery].

Barbelanne A, Wolf S, Foiry AF, Guillot C, Aron Wisnewsky J.

Soins. 2016 Dec;61(811):55-57. doi: 10.1016/j.soin.2016.10.013. French.

26.

[The care pathway in weight loss surgery].

Vignot M, Bernat M, Oppert JM, Basdevant Oppert A, Aron-Wisnewsky J.

Soins. 2016 Dec;61(811):37-38. doi: 10.1016/j.soin.2016.10.008. French.

27.

[Summary].

Aron Wisnewsky J, Disse E.

Soins. 2016 Dec;61(811):28-30. doi: 10.1016/j.soin.2016.10.005. French.

28.

Systematic review of bariatric surgery liver biopsies clarifies the natural history of liver disease in patients with severe obesity.

Bedossa P, Tordjman J, Aron-Wisnewsky J, Poitou C, Oppert JM, Torcivia A, Bouillot JL, Paradis V, Ratziu V, Clément K.

Gut. 2017 Sep;66(9):1688-1696. doi: 10.1136/gutjnl-2016-312238. Epub 2016 Nov 24. Review.

PMID:
27884920
29.

AdipoScan: A Novel Transient Elastography-Based Tool Used to Non-Invasively Assess Subcutaneous Adipose Tissue Shear Wave Speed in Obesity.

Sasso M, Liu Y, Aron-Wisnewsky J, Bouillot JL, Abdennour M, Clet M, Sandrin L, le Naour G, Bedossa P, Tordjman J, Clément K, Miette V.

Ultrasound Med Biol. 2016 Oct;42(10):2401-13. doi: 10.1016/j.ultrasmedbio.2016.06.016. Epub 2016 Jul 26.

PMID:
27471115
30.

Nonalcoholic fatty liver disease and obstructive sleep apnea.

Aron-Wisnewsky J, Clement K, Pépin JL.

Metabolism. 2016 Aug;65(8):1124-35. doi: 10.1016/j.metabol.2016.05.004. Epub 2016 May 13. Review.

PMID:
27324067
31.

Loss of the co-repressor GPS2 sensitizes macrophage activation upon metabolic stress induced by obesity and type 2 diabetes.

Fan R, Toubal A, Goñi S, Drareni K, Huang Z, Alzaid F, Ballaire R, Ancel P, Liang N, Damdimopoulos A, Hainault I, Soprani A, Aron-Wisnewsky J, Foufelle F, Lawrence T, Gautier JF, Venteclef N, Treuter E.

Nat Med. 2016 Jul;22(7):780-91. doi: 10.1038/nm.4114. Epub 2016 Jun 6.

PMID:
27270589
32.

Statins, antidiabetic medications and liver histology in patients with diabetes with non-alcoholic fatty liver disease.

Nascimbeni F, Aron-Wisnewsky J, Pais R, Tordjman J, Poitou C, Charlotte F, Bedossa P, Poynard T, Clément K, Ratziu V; LIDO study Group.

BMJ Open Gastroenterol. 2016 Mar 18;3(1):e000075. doi: 10.1136/bmjgast-2015-000075. eCollection 2016.

33.

Hypoxia-inducible factor prolyl hydroxylase 1 (PHD1) deficiency promotes hepatic steatosis and liver-specific insulin resistance in mice.

Thomas A, Belaidi E, Aron-Wisnewsky J, van der Zon GC, Levy P, Clement K, Pepin JL, Godin-Ribuot D, Guigas B.

Sci Rep. 2016 Apr 20;6:24618. doi: 10.1038/srep24618.

34.

Nutritional and Protein Deficiencies in the Short Term following Both Gastric Bypass and Gastric Banding.

Aron-Wisnewsky J, Verger EO, Bounaix C, Dao MC, Oppert JM, Bouillot JL, Chevallier JM, Clément K.

PLoS One. 2016 Feb 18;11(2):e0149588. doi: 10.1371/journal.pone.0149588. eCollection 2016.

35.

Is Bariatric Surgery Effective in Reducing Comorbidities and Drug Costs?: Letter to the editor.

Gesquiere I, Aron-Wisnewsky J.

Obes Surg. 2016 Apr;26(4):856. doi: 10.1007/s11695-016-2045-z. No abstract available.

PMID:
26744285
36.

The gut microbiome, diet, and links to cardiometabolic and chronic disorders.

Aron-Wisnewsky J, Clément K.

Nat Rev Nephrol. 2016 Mar;12(3):169-81. doi: 10.1038/nrneph.2015.191. Epub 2015 Nov 30. Review.

PMID:
26616538
37.

Accumulation and Changes in Composition of Collagens in Subcutaneous Adipose Tissue After Bariatric Surgery.

Liu Y, Aron-Wisnewsky J, Marcelin G, Genser L, Le Naour G, Torcivia A, Bauvois B, Bouchet S, Pelloux V, Sasso M, Miette V, Tordjman J, Clément K.

J Clin Endocrinol Metab. 2016 Jan;101(1):293-304. doi: 10.1210/jc.2015-3348. Epub 2015 Nov 19.

PMID:
26583585
38.

Impact of effective versus sham continuous positive airway pressure on liver injury in obstructive sleep apnoea: Data from randomized trials.

Jullian-Desayes I, Tamisier R, Zarski JP, Aron-Wisnewsky J, Launois-Rollinat SH, Trocme C, Levy P, Joyeux-Faure M, Pepin JL.

Respirology. 2016 Feb;21(2):378-85. doi: 10.1111/resp.12672. Epub 2015 Nov 16.

39.

[Bariatric surgery in obese adolescents: When and how should the transition from pediatric to adult medical management be made?].

Paepegaey AC, Dubern B, Karsenty A, Chantereau H, Aron-Wisnewsky J, Oderda L, Hadoux M, Robert-Gary A, Bouillot JL, Oppert JM, Tounian P, Poitou C.

Arch Pediatr. 2015 Dec;22(12):1233-9. doi: 10.1016/j.arcped.2015.09.010. French.

PMID:
26527542
40.

Micronutrient and Protein Deficiencies After Gastric Bypass and Sleeve Gastrectomy: a 1-year Follow-up.

Verger EO, Aron-Wisnewsky J, Dao MC, Kayser BD, Oppert JM, Bouillot JL, Torcivia A, Clément K.

Obes Surg. 2016 Apr;26(4):785-96. doi: 10.1007/s11695-015-1803-7.

PMID:
26205215
41.

Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology.

Dao MC, Everard A, Aron-Wisnewsky J, Sokolovska N, Prifti E, Verger EO, Kayser BD, Levenez F, Chilloux J, Hoyles L; MICRO-Obes Consortium, Dumas ME, Rizkalla SW, Doré J, Cani PD, Clément K.

Gut. 2016 Mar;65(3):426-36. doi: 10.1136/gutjnl-2014-308778. Epub 2015 Jun 22.

42.

New insights in the pathophysiology of chronic intermittent hypoxia-induced NASH: the role of gut-liver axis impairment.

Aron-Wisnewsky J, Pepin JL.

Thorax. 2015 Aug;70(8):713-5. doi: 10.1136/thoraxjnl-2015-207212. Epub 2015 Jun 16. No abstract available.

PMID:
26082141
43.

Irf5 deficiency in macrophages promotes beneficial adipose tissue expansion and insulin sensitivity during obesity.

Dalmas E, Toubal A, Alzaid F, Blazek K, Eames HL, Lebozec K, Pini M, Hainault I, Montastier E, Denis RG, Ancel P, Lacombe A, Ling Y, Allatif O, Cruciani-Guglielmacci C, André S, Viguerie N, Poitou C, Stich V, Torcivia A, Foufelle F, Luquet S, Aron-Wisnewsky J, Langin D, Clément K, Udalova IA, Venteclef N.

Nat Med. 2015 Jun;21(6):610-8. doi: 10.1038/nm.3829. Epub 2015 May 4.

PMID:
25939064
44.

Bariatric Surgery Induces Disruption in Inflammatory Signaling Pathways Mediated by Immune Cells in Adipose Tissue: A RNA-Seq Study.

Poitou C, Perret C, Mathieu F, Truong V, Blum Y, Durand H, Alili R, Chelghoum N, Pelloux V, Aron-Wisnewsky J, Torcivia A, Bouillot JL, Parks BW, Ninio E, Clément K, Tiret L.

PLoS One. 2015 May 4;10(5):e0125718. doi: 10.1371/journal.pone.0125718. eCollection 2015.

45.

Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients.

Magalhaes I, Pingris K, Poitou C, Bessoles S, Venteclef N, Kiaf B, Beaudoin L, Da Silva J, Allatif O, Rossjohn J, Kjer-Nielsen L, McCluskey J, Ledoux S, Genser L, Torcivia A, Soudais C, Lantz O, Boitard C, Aron-Wisnewsky J, Larger E, Clément K, Lehuen A.

J Clin Invest. 2015 Apr;125(4):1752-62. doi: 10.1172/JCI78941. Epub 2015 Mar 9.

46.

Circulating phospholipid profiling identifies portal contribution to NASH signature in obesity.

Anjani K, Lhomme M, Sokolovska N, Poitou C, Aron-Wisnewsky J, Bouillot JL, Lesnik P, Bedossa P, Kontush A, Clement K, Dugail I, Tordjman J.

J Hepatol. 2015 Apr;62(4):905-12. doi: 10.1016/j.jhep.2014.11.002. Epub 2014 Nov 8.

PMID:
25450212
47.

Type 2 Diabetes Remission After Gastric Bypass: What Is the Best Prediction Tool for Clinicians?

Cotillard A, Poitou C, Duchâteau-Nguyen G, Aron-Wisnewsky J, Bouillot JL, Schindler T, Clément K.

Obes Surg. 2015 Jul;25(7):1128-32. doi: 10.1007/s11695-014-1511-8.

48.

The effects of gastrointestinal surgery on gut microbiota: potential contribution to improved insulin sensitivity.

Aron-Wisnewsky J, Clement K.

Curr Atheroscler Rep. 2014 Nov;16(11):454. doi: 10.1007/s11883-014-0454-9. Review.

PMID:
25214424
49.

Response.

Pépin JL, Minville C, Hilleret MN, Tamisier R, Aron-Wisnewsky J, Clément K, Trocme C, Borel JC, Lévy P, Zarski JP.

Chest. 2014 Aug;146(2):e67-8. doi: 10.1378/chest.14-0981. No abstract available.

PMID:
25091773
50.

Medication cost is significantly reduced after Roux-en-Y gastric bypass in obese patients.

Gesquiere I, Aron-Wisnewsky J, Foulon V, Haggege S, Van der Schueren B, Augustijns P, Bouillot JL, Clement K, Basdevant A, Oppert JM, Buyse M.

Obes Surg. 2014 Nov;24(11):1896-903. doi: 10.1007/s11695-014-1325-8.

PMID:
24947346

Supplemental Content

Loading ...
Support Center